Health Bureau announces details of Chronic Disease Co-Care Pilot Scheme
HKSAR Government Press Releases· 41 分鐘前The Health Bureau announced today (September 25) details of the Chronic Disease Co-Care Pilot Scheme (CDCC Pilot Scheme) ...
Eisai’s Alzheimer’s Drug Wins Approval in Japan, Following US
Bloomberg· 2 小時前Eisai Co.’s breakthrough Alzheimer’s disease drug won clearance from Japanese regulators after the medicine ...
Police crackdown on youth crime in Tseung Kwan O results in arrests for drug trafficking, ...
Dimsum Daily· 2 小時前25th September 2023 – (Hong Kong) In an enforcement operation, the Tseung Kwan O police ...
Japan approves Alzheimer treatment Leqembi by Eisai and Biogen
Reuters· 3 小時前-based Biogen (BIIB.O). The development comes after a health ministry panel recommended the drug's approval ...
Japan's Nikkei rebounds from worst week of 2023 after clearing BOJ, Fed tests
Reuters· 4 小時前Japan’s Nikkei share average rebounded sharply on Monday, as investors bought back beaten-down stocks after major risk events ...
China capable of shielding astronauts from effects of weightlessness in space
China Daily· 5 小時前Progress in this area has provided theoretical support and a technical platform for research into cardiovascular health, ...
HK Government launches Chronic Disease Co-Care Pilot Scheme to promote early prevention and ...
Dimsum Daily· 5 小時前25th September 2023 – (Hong Kong) The Hong Kong Health Bureau has announced the details of the ...
China healthcare a unique multidecade investment bet
China Daily· 6 小時前The recent monetary and fiscal stimulus measures introduced by the central and local governments in China are boosting investment ...
Wild rave party held in front of Tin Hau Temple in Clear Water Bay irks local residents, ...
Dimsum Daily· 6 小時前25th September 2023 – (Hong Kong) Tin Hau Temple, located in the serene surroundings of Clear ...
咳嗽要分清乾咳、濕咳！有痰的咳嗽與脾胃濕有關！為甚麼吃川貝枇杷膏、蜂蜜愈食愈咳？即睇化痰止咳良 ...
經濟通· 7 小時前Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review, Drug Safety ...
